Sentences with phrase «in people with schizophrenia»
The protein is elevated in people with schizophrenia and other severe mental illnesses, but the study is the first to investigate how it causes such severe mental illness.
sciencedaily.com
Brain and nervous system effects range from mood disruption, such as depression, to behavioral outbursts in children with ADHD and autism, to triggering of hallucinations in people with schizophrenia and mania in people with bipolar illness.
In the new study, Soderling, postdoctoral researcher Il Hwan Kim, and their team characterized three brain abnormalities in the Arp2 / 3 mice that also appear in people with schizophrenia.
Leweke's team also found anandamide levels lowest in people with schizophrenia who used cannabis more frequently, suggesting it may disrupt the system in other ways too.
Do antipsychotic medications differ in the ability to reduce violent behaviour in people with schizophrenia?
Researchers in Hong Kong have found reduced activity in the Igf2 gene in people with schizophrenia.
A GENE mutation that alters the shape of the brain in some people with schizophrenia could help explain why the disease often strikes at adolescence.
A new study from Parker's lab and the lab of Nandakumar Narayanan at the University of Iowa Carver College of Medicine finds that stimulating the cerebellum in rats with schizophrenia - like thinking problems normalizes brain activity in the frontal cortex and corrects the rats» ability to estimate the passage of time — a cognitive deficit that is characteristic in people with schizophrenia.
Yet MRI scans of the 1 - year - old juveniles — equivalent in age to a 5 to 7 - year - old human child — revealed that their brains had features similar to those seen in people with schizophrenia, including less grey matter in the cortex and enlarged ventricles.
However, recent laboratory studies have shown that hedonic experience is actually intact in people with schizophrenia, calling for new approaches to better understand these motivational deficits.
One gene, called ZNF659, showed over-methylation in people with schizophrenia and under - methylation in those who were bipolar, suggesting that the conditions might result from opposing gene activity (Human Molecular Genetics, DOI: 10.1093 / hmg / ddr416).
Published in Nature Neuroscience, this new study lends support to the direct influence on creativity of genes found in people with schizophrenia and bipolar disorder.
The drug is not an antipsychotic, but instead strengthens the signaling of glutamate, a neurotransmitter that's impaired in people with schizophrenia and those at risk.
Meanwhile, other research teams have reported a smaller - than - usual spike at N170 in people with schizophrenia.
As in people with schizophrenia, excessive spine pruning seems to occur earlier in life.
A second observation in people with schizophrenia is hyperactive neurons, which are also in the front of the brain, a region that is involved in planning and decision - making.
This imbalance within the brain is thought to cause hallucinations and paranoia in people with schizophrenia.
Alcohol and drug use disorders are believed to have substantial negative effects on outcomes in people with schizophrenia.
Sure enough, when Markus Leweke of the University of Cologne, Germany, and Andrea Giuffrida and Danielle Piomelli of the University of California, Irvine, looked at levels of the natural cannabis - like substance anandamide, they were higher in people with schizophrenia than in healthy controls.
Neuroimaging studies have found that certain parts of the brain, such as the hippocampus and amygdala, are smaller in people with schizophrenia — a devastating psychiatric illness with high heritability.
New research from the Centre for Addiction and Mental Health (CAMH) shows a significant relationship between motivational deficit and poor cognitive performance in people with schizophrenia.
«Specifically, this paper shows that parts of the brain's cortex develop differently in people with schizophrenia,» said first author Dr. Aaron F. Alexander - Bloch, from the National Institute of Mental Health.
«Topics were focused on cognition, genetics, and EEG and MRI research — information converging on brain abnormalities in people with schizophrenia.»
Early research suggests that taking DHA, eicosapentaenoic acid (EPA), and alpha - lipoic acid for 2 years does not prevent symptoms from returning in people with schizophrenia who stop taking their medication.
Current use of second - generation antipsychotics may increase risk of pneumonia in people with schizophrenia
Atypical antipsychotics not associated with improved hospitalisation outcomes compared with typical antipsychotics in people with schizophrenia in real practice
Review: no clear benefit from information and communication technology - delivered support and education compared with standard care in people with schizophrenia
Trauma and posttraumatic stress disorder in people with schizophrenia.
Is bupropion safe and effective for achieving abstinence from smoking and reducing nicotine dependence in people with schizophrenia?
Bupropion reduces nicotine dependence and increases smoking cessation compared with control in people with schizophrenia, without affecting positive, negative or depressive symptoms.
Brain activity during hallucinations in a person with schizophrenia (Image: Wellcome department of cognitive neurology / Science Photo Library)
Antipsychotic medications, a mainstay of treatment for schizophrenia, alleviated some of the animals» symptoms.In the new study, Soderling, postdoctoral researcher Il Hwan Kim, and their team characterized three brain abnormalities in the Arp2 / 3 mice that also appear in people with schizophrenia.
Antipsychotic medications do not differ substantially in ability to reduce violent behaviour in people with schizophrenia
In people with schizophrenia, for example, the ability to perceive another person's emotional state canaccurately predict social functioning more broadly.
Two RCTs reported cannabis use outcomes following pharmacological interventions: one in people with major depression, alcohol dependence and cannabis abuse diagnoses (n = 22; fluoxetine vs placebo) and one in people with schizophrenia and cannabis and / or cocaine use disorders (n = 28; olanzapine vs risperidone).